Publications by authors named "E Vanegas"

Kaposi sarcoma (KS) is an angioproliferative disorder caused by human herpesvirus-8 (HHV-8) infection. KS manifests as vascular and mucosal nodules and is classified into four subtypes based on epidemiology, clinical presentation, histopathology, and HHV-8/human immunodeficiency virus serology. Here, we present a unique case of classic KS in an 84-year-old immunocompetent Haitian male patient, highlighting the rarity of this variant in this population.

View Article and Find Full Text PDF

Background: Compared with conventional cigarettes, electronic cigarettes are less harmful in some studies. However, recent research may indicate the opposite. This study aimed to determine whether e-cigarette use is related to myocardial health in adults in the U.

View Article and Find Full Text PDF

Contamination with traces of pharmaceutical compounds, such as ciprofloxacin, has prompted interest in their removal via low-cost, efficient biomass-based adsorption. In this study, classical models, a mechanistic model, and a neural network model were evaluated for predicting ciprofloxacin breakthrough curves in both laboratory- and pilot scales. For the laboratory-scale (d = 2.

View Article and Find Full Text PDF

Mucopolysaccharidosis type IIIB (MPS IIIB) is an autosomal inherited disease caused by mutations in gene encoding the lysosomal enzyme N-acetyl-alpha-glucosaminidase (NAGLU). These mutations result in reduced NAGLU activity, preventing it from catalyzing the hydrolysis of the glycosaminoglycan heparan sulfate (HS). There are currently no approved treatments for MPS IIIB.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate Ecuadorian physicians' knowledge and perceptions of pulmonary rehabilitation for patients post-COVID-19, highlighting its importance for improving respiratory function and well-being.
  • - An online survey of 295 physicians revealed that while a majority recognized the need for respiratory follow-up in COVID-19 patients (81.4%), only 18.3% were aware of specific rehabilitation guidelines.
  • - Overall, 93.6% of participants believed pulmonary rehabilitation is beneficial for patients with a history of COVID-19, but there is still uncertainty regarding the proper follow-up and implementation of rehabilitation strategies.
View Article and Find Full Text PDF